Zürcher Nachrichten - Who should get paid for nature's sequenced genes?

EUR -
AED 3.97537
AFN 71.968763
ALL 98.653827
AMD 418.887624
ANG 1.950918
AOA 986.536568
ARS 1069.063811
AUD 1.64963
AWG 1.948179
AZN 1.841713
BAM 1.96044
BBD 2.185653
BDT 129.356182
BGN 1.956291
BHD 0.407878
BIF 3146.850703
BMD 1.082322
BND 1.434796
BOB 7.479635
BRL 6.235692
BSD 1.082452
BTN 90.993379
BWP 14.530326
BYN 3.542585
BYR 21213.507748
BZD 2.181944
CAD 1.505721
CDF 3149.556657
CHF 0.938349
CLF 0.037508
CLP 1034.970294
CNY 7.718256
CNH 7.705368
COP 4758.038263
CRC 555.715362
CUC 1.082322
CUP 28.681528
CVE 110.910954
CZK 25.35337
DJF 192.349878
DKK 7.460065
DOP 65.369431
DZD 144.356929
EGP 52.720651
ERN 16.234827
ETB 130.746641
FJD 2.468345
FKP 0.828159
GBP 0.831564
GEL 2.955031
GGP 0.828159
GHS 17.598471
GIP 0.828159
GMD 75.220879
GNF 9340.437276
GTQ 8.367806
GYD 226.473965
HKD 8.410885
HNL 27.112473
HRK 7.456148
HTG 142.657666
HUF 405.286205
IDR 17071.678592
ILS 4.029148
IMP 0.828159
INR 90.996478
IQD 1417.841589
IRR 45571.160414
ISK 148.515971
JEP 0.828159
JMD 171.255356
JOD 0.767256
JPY 165.770606
KES 139.074242
KGS 92.85891
KHR 4405.050018
KMF 492.94367
KPW 974.089397
KRW 1498.263515
KWD 0.331905
KYD 0.902135
KZT 530.646024
LAK 23740.729539
LBP 97435.480608
LKR 317.892442
LRD 207.860116
LSL 19.135204
LTL 3.195814
LVL 0.654686
LYD 5.216719
MAD 10.663573
MDL 19.403929
MGA 4994.915534
MKD 61.629624
MMK 3515.339065
MNT 3677.729588
MOP 8.662424
MRU 43.293454
MUR 50.024422
MVR 16.62432
MWK 1875.124288
MXN 21.708827
MYR 4.729338
MZN 69.170924
NAD 19.134983
NGN 1783.806819
NIO 39.832159
NOK 11.859211
NPR 145.589606
NZD 1.811617
OMR 0.41672
PAB 1.082452
PEN 4.08255
PGK 4.342241
PHP 63.132954
PKR 300.556481
PLN 4.34042
PYG 8617.397125
QAR 3.940196
RON 4.975441
RSD 117.072568
RUB 105.525928
RWF 1471.95768
SAR 4.064827
SBD 9.019574
SCR 15.861617
SDG 650.986187
SEK 11.515239
SGD 1.432264
SHP 0.828159
SLE 24.57449
SLL 22695.744024
SOS 618.005565
SRD 37.153957
STD 22401.876555
SVC 9.471419
SYP 2719.366342
SZL 19.135408
THB 36.433133
TJS 11.528381
TMT 3.788126
TND 3.363314
TOP 2.534908
TRY 37.101798
TTD 7.336365
TWD 34.70606
TZS 2949.326911
UAH 44.772268
UGX 3967.353954
USD 1.082322
UYU 45.047041
UZS 13864.54288
VEF 3920767.666156
VES 45.644616
VND 27393.565362
VUV 128.495454
WST 3.031783
XAF 657.501136
XAG 0.032086
XAU 0.000398
XCD 2.925029
XDR 0.813626
XOF 655.886801
XPF 119.331742
YER 270.932224
ZAR 19.112741
ZMK 9742.192272
ZMW 28.820952
ZWL 348.507186
  • RBGPF

    62.3500

    62.35

    +100%

  • CMSC

    -0.1600

    24.57

    -0.65%

  • SCS

    -0.3800

    12.21

    -3.11%

  • BCC

    -6.9800

    131.64

    -5.3%

  • BTI

    -0.4500

    34.46

    -1.31%

  • RIO

    0.4000

    66.58

    +0.6%

  • GSK

    0.2900

    38.17

    +0.76%

  • BP

    -1.6900

    29.36

    -5.76%

  • CMSD

    -0.0400

    24.84

    -0.16%

  • NGG

    -0.8800

    65.12

    -1.35%

  • RYCEF

    0.0400

    7.25

    +0.55%

  • BCE

    -0.2300

    32.46

    -0.71%

  • RELX

    -0.2500

    47.91

    -0.52%

  • JRI

    -0.0900

    12.98

    -0.69%

  • AZN

    -0.7900

    75.22

    -1.05%

  • VOD

    -0.2600

    9.28

    -2.8%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

N.Zaugg--NZN